Sign Out
Intensive Care Unit Sedation: Dexmedetomidine Hydrochloride is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting.
Dexmedetomidine Hydrochloride should be administered by continuous infusion not to exceed 24 hours. Dexmedetomidine Hydrochloride has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. It is not necessary to discontinue Dexmedetomidine Hydrochloride prior to extubation.
Procedural Sedation: Dexmedetomidine Hydrochloride is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures.
Continue with Google